Edesa Biotech (EDSA) Operating Margin (2013 - 2020)
Edesa Biotech (EDSA) posted Operating Margin of 402094.8% for Q3 2020, down 24907.66% sequentially from 1607.89% in Q2 2020.
Edesa Biotech (EDSA) Operating Margin (2013 - 2020) Analysis & Trends
Edesa Biotech has reported Operating Margin for 8 years, with the latest figure at 402094.8% in Q3 2020.
- Quarterly Operating Margin changed N/A year-over-year to 402094.8% in Q3 2020, while the trailing twelve-month figure through Jun 2021 was 4041457.2% (down 403955590.0% YoY) and the FY2020 annual result came in at 1946.72%, down 125742.0% from the prior year.
- Operating Margin eased to 402094.8% in Q3 2020 per EDSA's latest filing, from 1607.89% in the prior quarter.
- Over five years, Operating Margin peaked at 780.41% in Q3 2017 and troughed at 402094.8% in Q3 2020.
- A 5-year average of 56903.19% and a median of 1489.93% in 2020 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2017 and 2020: Operating Margin slumped 578708 bps in 2017, then soared 37061771 bps in 2020.
- Over 5 years, Operating Margin stood at 997.12% in 2016, then slumped by 580 bps to 6784.2% in 2017, then jumped by 69 bps to 2098.07% in 2018, then surged by 51 bps to 1025.68% in 2019, then tumbled by 39103 bps to 402094.8% in 2020.
- According to Business Quant data, Operating Margin over the past three periods registered 402094.8%, 1607.89%, and 1371.98% for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -402,094.80% |
| Jun 30, 2020 | -1,607.89% |
| Mar 31, 2020 | -1,371.98% |
| Dec 31, 2019 | -1,025.68% |
| Jun 30, 2019 | -372,225.60% |
| Mar 31, 2018 | -2,098.07% |
| Dec 31, 2017 | -6,784.20% |
| Sep 30, 2017 | 780.41% |
| Jun 30, 2017 | -6,300.49% |
| Mar 31, 2017 | -1,820.97% |
| Dec 31, 2016 | -997.12% |
| Sep 30, 2016 | -106.20% |
| Jun 30, 2016 | -656.28% |
| Mar 31, 2016 | -335.83% |
| Dec 31, 2015 | -286.60% |
| Sep 30, 2015 | 492.89% |
| Jun 30, 2015 | -702.12% |
| Mar 31, 2015 | -1,036.09% |
| Dec 31, 2014 | -668.36% |
| Dec 31, 2013 | -10,871.95% |